Track the Lexaria Bioscience Corp. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Health Care sector, Lexaria Bioscience Corp. has recorded 13 reports. Market capitalisation: €14.4m. The latest transaction was reported on 10 January 2025 (Attribution). Among the most active insiders: BUNKA CHRISTOPHER. Every trade is free.
13
Insider Decl.
0
Thresholds
€102,237
5 ops.
Buy Volume
€9,486
1 ops.
Sell Volume
39Σ signal
Buys €102,237€9,486 Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 22,360 of 26,211 companies
26.3
score / 100
Value
3
Quality
49
FCF yld-61%
Earn yld-69%
EV/EBITDA·
ROE-147%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.